BK

BNY Mellon Q2 Earnings Surge 16%

The Bank of New York Mellon Corporation (BNY) has reported its financial results for the second quarter of 2024, with earnings per common share coming in at $1.52, representing a 16% increase year-over-year. Adjusted earnings per share, excluding notable items, were $1.51, marking a 9% increase from the same period last year.

Total revenue for the quarter reached $4.6 billion, a 2% increase from the previous year. Noninterest expense decreased by 1%, or increased by 1% excluding notable items. Net income applicable to common shareholders rose by 20% year-over-year to $1.143 billion.

The company's financial ratios also demonstrated positive trends, with the pre-tax operating margin at 33%, an improvement from the previous quarter's 29%, and return on tangible common equity (ROTCE) at 24.6%, an increase from the previous quarter's 22.8%.

In terms of assets under custody and/or administration (AUC/A), BNY saw a 1% increase to $49.5 trillion, while assets under management (AUM) rose by 1% to $2.0 trillion.

The bank also increased its common dividend by 12% following the release of the Federal Reserve's 2024 bank stress test results in June.

Looking at the business segments, the securities services business reported a 2% increase in total revenue, driven by a 3% increase in investment services fees and a 16% increase in foreign exchange revenue.

Meanwhile, the market and wealth services business segment saw a 1% increase in total revenue, with a 2% increase in investment services fees and a 10% increase in foreign exchange revenue.

The investment and wealth management business segment experienced a 1% decrease in total revenue, with a 2% decrease in investment management fees and a 10% decrease in net interest income.

Following these announcements, the company's shares moved 5.3%, and are now trading at a price of $64.75. For the full picture, make sure to review Bank of New York Mellon's 8-K report.

The above analysis is intended for educational purposes only and was performed on the basis of publicly available data. It is not to be construed as a recommendation to buy or sell any security. Any buy, sell, or other recommendations mentioned in the article are direct quotations of consensus recommendations from the analysts covering the stock, and do not represent the opinions of Market Inference or its writers. Past performance, accounting data, and inferences about market position and corporate valuation are not reliable indicators of future price movements. Market Inference does not provide financial advice. Investors should conduct their own review and analysis of any company of interest before making an investment decision.

IN FOCUS